You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search
Drug Formulary
About the Drug Formulary Email Drug Formulary Team

riTUXimab

( rit-TUCKS-ee-mab )
Funding:
New Drug Funding Program
  • Rituximab - Single Agent - Indolent Lymphoma
  • Rituximab - Previously Untreated Chronic Lymphocytic Leukemia
  • Rituximab - Maintenance Treatment - Lymphoma
  • Rituximab - Second Line - Chronic Lymphocytic Leukemia
  • Rituximab - Retreatment - Indolent Lymphoma
  • Rituximab - Aggressive Histology Lymphoma
  • Rituximab in Combination with Chemotherapy - Indolent B-cell Lymphoma
  • Rituximab - HIV-Related, Aggressive Histology, B-cell Lymphoma
  • Rituximab - In Combination with Idelalisib - Relapsed Chronic Lymphocytic Leukemia
... Show more tags
Other Name(s): Rituxan® ()
Appearance: Clear, colourless solution mixed into larger bags of fluids

Drug Monograph

Jul 2018
Table of Contents
Eligibility Forms
pdf download Rituximab - Aggressive Histology Lymphoma pdf download Rituximab - HIV-Related - Aggressive Histology - B-cell Lymphoma pdf download Rituximab - In Combination with Idelalisib - Relapsed Chronic Lymphocytic Leukemia pdf download Rituximab - Maintenance Treatment - Lymphoma pdf download Rituximab - Previously Untreated Chronic Lymphocytic Leukemia pdf download Rituximab - Second Line - Chronic Lymphocytic Leukemia pdf download Rituximab in Combination with Chemotherapy - Indolent B-cell Lymphoma pdf download Rituximab - Retreatment - Indolent Lymphoma pdf download Rituximab - Single Agent - Indolent Lymphoma pdf download Rituximab - As Part of the MATRix Regimen in Newly Diagnosed, Previously Untreated PCNSL

Patient Info Sheet

Jul 2018

What it is used for

• For treating blood cancers such as non-Hodgkin's lymphoma or chronic lymphocytic leukemia (CLL)



You might also be interested in

Funding & Reimbursement

Several payment sources exist for cancer drugs in Ontario, depending on the drug, disease indication, and how and where it is delivered.

View Funding & Reimbursement

Symptom Management

Many people living with cancer experience nausea, diarrhea and other symptoms from their treatment or disease.

View Symptom Management

Drug Safety and Administration

Find documents on drug safety and administration for healthcare providers, including calculations and recommendations.

View Drug Safety and Administration